Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Well, you say..."The issue would be whether the FDA would require a further larger study using Crestor/Apabetalone alone to replicate results."(assuming you mean for MACE)
So if we end up there would it not be more beneficial seeing that the combination of the two molecules saw a PAV plague regression of (-1.4%) in ASSURE well over the pre-specified endpoint of (-0.6%). Won't we end up with a drug for plaque regression and MACE?
